DW Kowalczyk, AP Wlazlo, M Blaszczyk-Thurin, ZQ Xiang, W Giles-Davis, HC Ertl. (2001) " A method that allows easy characterization of tumor-infiltrating lymphocytes. " J Immunol Methods 253. 163-75 PMID: 11384678 | Abstract and Keywords

T Verch, ZK Pan, Y Paterson. (2004) " Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines. " Infect Immun 72. 6418-25 PMID: 15501772 DOI: 10.1128/IAI.72.11.6418-6425.2004 | Abstract and Keywords

A Albers, K Abe, J Hunt, J Wang, A Lopez-Albaitero, C Schaefer, W Gooding, TL Whiteside, S Ferrone, A DeLeo, RL Ferris. (2005) " Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. " Cancer Res 65. 11146-55 PMID: 16322265 DOI: 10.1158/0008-5472.CAN-05-0772 | Abstract and Keywords

KB Gendron, A Rodriguez, DA Sewell. (2006) " Vaccination with human papillomavirus type 16 E7 peptide with CpG oligonucleotides for prevention of tumor growth in mice. " Arch Otolaryngol Head Neck Surg 132. 327-32 PMID: 16549754 DOI: 10.1001/archotol.132.3.327 | Abstract and Keywords

J Hu, X Peng, TD Schell, LR Budgeon, NM Cladel, ND Christensen. (2006) " An HLA-A2.1-transgenic rabbit model to study immunity to papillomavirus infection. " J Immunol 177. 8037-45 PMID: 17114477 | Abstract and Keywords

X Wang, AB Moscicki, L Tsang, A Brockman, M Nakagawa. (2008) " Memory T cells specific for novel human papillomavirus type 16 (HPV16) E6 epitopes in women whose HPV16 infection has become undetectable. " Clin Vaccine Immunol 15. 937-45 PMID: 18448624 DOI: 10.1128/CVI.00404-07 | Abstract and Keywords

J Hu, N Cladel, K Balogh, N Christensen. (2010) " Mucosally delivered peptides prime strong immunity in HLA-A2.1 transgenic rabbits. " Vaccine 28. 3706-13 PMID: 20332046 DOI: 10.1016/j.vaccine.2010.03.015 | Abstract and Keywords

S Kanodia, DM Da Silva, T Karamanukyan, L Bogaert, YX Fu, WM Kast. (2010) " Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regression. " Cancer Res 70. 3955-64 PMID: 20460520 DOI: 10.1158/0008-5472.CAN-09-3773 | Abstract and Keywords